Press Releases
Takeda Announces Compelling Data from the Phase 2 Trial of Pevonedistat Plus Azacitidine in Patients with Higher-Risk MDS
Takeda Pharmaceutical Company Limited announced the results of the Phase 2 Pevonedistat-2001 trial will be presented during oral sessions at the virtual 56th American Society of Clinical Oncology (ASCO) Annual Meeting and the virtual 25th European Hematology Association (EHA)...
Press Releases
FDA Approves Lilly’s Tauvid Imaging Agent to Help Diagnose Alzheimer’s Disease
There are two abnormal proteins associated with Alzheimer’s disease. The first is amyloid. The second is tau. Eli Lilly announced that the U.S. FDA approved its Tauvid, a radioactive diagnostic agent for PET imaging in Alzheimer’s patients. It is...
Press Releases
Medpharm: Our First Step Towards Manufacturing in the US
MedPharm Ltd, a world-leading contract developer of topical and transdermal pharmaceutical products, has taken the first steps to expand its manufacturing capacity in the US to complement an existing manufacturing facility in the UK. MedPharm has obtained a facility...
Clinical Trials
LabCorp Accelerates Adoption of Decentralized Clinical Trials, Expands Technology Ecosystem Through Alliance With Medable
LabCorp, a leading global life sciences company that is deeply integrated in guiding patient care, announced that Covance, its drug development business, is expanding its technology ecosystem to accelerate the adoption of decentralized clinical trials, often referred to as...
IT & Data Management
TraceLink Introduces New Agile Issue Management Solution
TraceLink, Inc., the leading digital platform company for the life science supply chain, unveiled Agile Issue Management™, a network-based supply chain solution that enables companies to collaboratively identify, document and resolve disruptive supply chain issues to ensure the availability...
Press Releases
Moderna Extends Lipid Supply for Coronavirus Vaccine
CordenPharma, a full-service Contract Development & Manufacturing Organization (CDMO) for the supply of APIs, Drug Products & Pharmaceutical Packaging, announces the signing of an amendment to their existing manufacturing agreement with Moderna, Inc., a clinical stage biotechnology company pioneering...
Press Releases
Lonza and Sanquin Partner for Commercialization of Specialized MAT Reagents for Accurate and Reliable in vitro Pyrogen Testing
Lonza Sales AG, through its Bioscience Division has joined forces with Sanquin Reagents B.V. to enable drug developers and quality control laboratories to take full advantage of the power of the Monocyte Activation Test (MAT)
The new partnership...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















